In addition, a murine model of SS revealed that metformin could ameliorate salivary gland inflammation by downregulating the expression of interleukin (IL)-6, tumor necrosis factor-α, and IL-17 in situ, maintaining the balance between effector T and Treg cells and controlling B cells differentiation (33). The gene discussed is IL6; the disease is synovial sarcoma.